“Cambridge-based Closed Loop Medicine (CLM) has secured £1.3m in research grant funding from the Innovate UK Innovation Accelerator, Longwall Ventures and IQ Capital, it was announced on Friday.

The new funds will see the British startup work with specialists from the Clinical Research Centre at the William Harvey Research Institute, Queen Mary University of London, on a new project to help patients with high blood pressure that have experienced medication side effects manage their condition.

“(…) By combining blood pressure measurement, drug and non-drug therapies in a closed loop via a smartphone app, CLM will demonstrate that individual treatments can be optimised for patients,” the startup explained in a press announcement.

The project will also seek to give patients more control over their care and reduce growing pressures on the NHS.”